Amedica Corp. (NASDAQ: AMDA) shares tumbled in Tuesday’s session following the announcement of the pricing of its secondary offering. The company is expecting to gain about $11 million in gross proceeds from this underwritten offering.
The underwriters for the offering are Ladenburg Thalmann and Maxim Group.
The company is pricing a total of 3.608 million shares of common stock Class A units at $1 per unit, with each unit consisting of one share of common stock and one five-year warrant to purchase one share of common stock with an exercise price of $1.00 per share.
